Table I.

IAP Immunization Timetable 2016

I. IAP recommended vaccines for routine use

Age
Vaccines Comments
(completed weeks/months/years)

Birth
BCG Administer these vaccines to all newborns before hospital
OPV 0 discharge
Hep-B 1

6 weeks
DTP:

DTwP 1 DTaP vaccine/combinations should preferably be

IPV 1 avoided for the primary series
Hep-B 2
Hib 1 DTaP vaccine/combinations should be preferred in
Rotavirus 1 certain specific circumstances/conditions only
PCV 1
No need of repeating/giving additional doses of whole-
cell pertussis (wP) vaccine to a child who has earlier
completed their primary schedule with acellular
pertussis (aP) vaccine-containing products

Polio:
 All doses of IPV may be replaced with OPV if
administration of the former is unfeasible

Additional doses of OPV on all supplementary

immunization activities (SIAs)

Two doses of IPV instead of 3 for primary series if

started at 8 weeks, and 8 weeks interval between the
doses

No child should leave the facility without polio

immunization (IPV or OPV), if indicated by the
schedule

See footnotes under figure titled IAP recommended

immunization schedule (with range) for
recommendations on intradermal IPV

Rotavirus:

2 doses of RV1 and 3 doses of RV5 & RV 116E

RV1 should be employed in 10 & 14 week schedule,
10 & 14 week schedule of RV1 is found to be more
immunogenic than 6 & 10 week schedule

10 weeks DTwP 2
IPV 2 Rotavirus:
Hib 2
Rotavirus 2 If RV1 is chosen, the first dose should be given at 10 weeks
PCV 2

14 weeks DTwP 3
 IPV 3 Rotavirus:
Hib 3
Rotavirus 3 Only 2 doses of RV1 are recommended.
PCV 3 If RV1 is chosen, the 2nd dose should be given at 14
weeks
6 months OPV 1
Hep-B 3 Hepatitis-B: The final (3rd or 4th ) dose in the HepB vaccine
series should be administered no earlier than age 24 weeks and
at least 16 weeks after the first dose.

9 months OPV 2
MMR-1 MMR:
Measles-containing vaccine ideally should not be
administered before completing 270 days or 9 months
of life;

The 2nd dose must follow in 2nd year of life;

No need to give stand-alone measles vaccine

9-12 months Typhoid Conjugate Currently, two typhoid conjugate vaccines, Typbar-TCV
Vaccine and PedaTyph available in Indian market; either can
be used

An interval of at least 4 weeks with the MMR vaccine

should be maintained while administering this vaccine

12 months Hep-A 1
Hepatitis A:
Single dose for live attenuated H2-strain Hep-A
vaccine
Two doses for all inactivated Hep-A vaccines are
 recommended

15 months MMR 2
Varicella 1 MMR:
PCV booster The 2nd dose must follow in 2nd year of life
However, it can be given at anytime 4-8 weeks after
the 1st dose

Varicella: The risk of breakthrough varicella is lower if given

15 months onwards

16 to 18 months DTwP B1/DTaP B1

IPV B1 The first booster (4thth dose) may be administered as early as
Hib B1 age 12 months, provided at least 6 months have elapsed since
the third dose.

DTP:
1st & 2nd boosters should preferably be of
DTwP

Considering a higher reactogenicity of DTwP,

DTaP can be considered for the boosters

18 months Hep-A 2
Hepatitis A: 2nd dose for inactivated vaccines only

2 years Booster of Typhoid

Conjugate Vaccine A booster dose of Typhoid conjugate vaccine (TCV), if
primary dose is given at 9-12 months

A dose of Typhoid Vi-polysaccharide (Vi-PS) vaccine

 can be given if conjugate vaccine is not available or
feasible;

Revaccination every 3 years with Vi-polysaccharide

vaccine

Typhoid conjugate vaccine should be preferred over

Vi- PS vaccine

4 to 6 years
DTwP B2/DTaP B2 Varicella: the 2nd dose can be given at anytime 3 months after
OPV 3 the 1st dose.
Varicella 2 MMR: the 3rd dose is recommended at 4-6 years of age.
MMR 3

10 to 12 years Tdap/Td
HPV Tdap: is preferred to Td followed by Td every 10 years

HPV:

Only 2 doses of either of the two HPV vaccines for

adolescent/preadolescent girls aged 9-14 years;

For girls 15 years and older, and immunocompromised

individuals 3 doses are recommended

For two-dose schedule, the minimum interval between

doses should be 6 months.

For 3 dose schedule, the doses can be administered at

0, 1-2 (depending on brand) and 6 months
 II. IAP recommended vaccines for High-risk* children (Vaccines under special circumstances) #:
1-Influenza Vaccine
2-Meningococcal Vaccine
3-Japanese Encephalitis Vaccine
4-Cholera Vaccine
5-Rabies Vaccine
6-Yellow Fever Vaccine
7-Pneumococcal Polysaccharide vaccine (PPSV 23)

* High-risk category of children:

Congenital or acquired immunodeficiency (including HIV infection),

Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including
nephrotic syndrome), liver disease and diabetes mellitus
Children on long term steroids, salicylates, immunosuppressive or radiation therapy
Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
Children with functional/ anatomic asplenia/ hyposplenia
During disease outbreaks
Laboratory personnel and healthcare workers
Travelers
Children having pets in home
Children perceived with higher threat of being bitten by dogs such as hostellers, risk of stray dog menace while going outdoor.

# For details see footnotes under figure titled 'IAP recommended immunization schedule (with range)'